Alexza Pharma (ALXA) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Alexza Reports 2015 Second Quarter Financial Results
August 6, 2015 4:06 PM EDTMOUNTAIN VIEW, Calif., Aug. 6, 2015 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter ended June 30, 2015. The net loss for the second quarter was $12.5 million compared to $6.0 million during the same quarter in 2014. The net loss for the six months ended June 30, 2015 and 2014 was $12.9 million and $16.7 million, respectively. At June 30, 2015, Alexza had consolidated cash, cash equivalents, and marketable securities of $15.7 million.
"We continue to see the incremental growth in the ADASUVE global launch. ADASUVE is now available in 18 countries and we see continued increases in... More
